Acute antibody-mediated rejection in pediatric kidney transplants: A single center experience

Katherine Twombley, Lonnie Thach, Annelise Ribeiro, Catherine Joseph, Mouin Seikaly

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


aAMR is a potentially devastating complication of kidney transplantation. The incidence of aAMR in children, while thought to be rare, is not well defined, and there is a paucity of data on treatment regimens in children. We retrospectively reviewed the outcomes of our pediatric patients that were treated for aAMR between 2007 and 2009. Three adolescent Hispanic males were found to have aAMR. All three received deceased donor transplants, and all three verbalized non-adherence. Treatment consisted of rituximab, solumedrol, PE, and IVIgG in one patient, and PE, IVIgG, and bortezomib in two patients. The only side effect of therapy noted was mild hypotension with rituximab that resolved after decreasing the infusion rate. There were no reported infections two yr after treatment, and all of the viral monitoring in these patients remained negative.

Original languageEnglish (US)
Pages (from-to)E149-E155
JournalPediatric Transplantation
Issue number7
StatePublished - Nov 1 2013


  • adolescents
  • anti-HLA antibody
  • antibodies
  • antibody mediated rejection
  • outcome
  • pediatric kidney transplant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Transplantation


Dive into the research topics of 'Acute antibody-mediated rejection in pediatric kidney transplants: A single center experience'. Together they form a unique fingerprint.

Cite this